Westerkirk Capital’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.3M Sell
32,131
-800
-2% -$90.3K 0.36% 59
2025
Q4
$4.13M Buy
32,931
+23,578
+252% +$3M 0.4% 52
2025
Q3
$1.25M Sell
9,353
-9,217
-50% -$1.21M 0.14% 123
2025
Q2
$2.53M Buy
+18,570
New +$2.45M 0.31% 66

Other funds holding ABT

Westerkirk Capital's ABT Position: Q1 2026 in Review

Westerkirk Capital reduced its Abbott (ABT) stake by 2.4% in Q1 2026, selling an estimated $90.3K and leaving 32,131 shares worth $3.3M. The position accounts for 0.36% of the portfolio, ranked #59.

Westerkirk Capital first reported a position in ABT in Q2 2025 and has held it in 4 quarters since. The position peaked at $4.13M in Q4 2025. 3,091 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Westerkirk Capital held 32,131 shares of Abbott worth $3.3M as of Q1 2026.
  • Westerkirk Capital sold 800 Abbott shares in Q1 2026, an estimated $90.3K.
  • Abbott made up 0.36% of Westerkirk Capital's portfolio in Q1 2026, its #59 holding.
  • Westerkirk Capital first reported a position in Abbott in Q2 2025 and has held it in 4 quarters since.
  • Westerkirk Capital's Abbott position peaked at $4.13M in Q4 2025.
  • 3,091 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Westerkirk Capital's 13F filing for Q1 2026, filed 14 May 2026.